Peter D Haytaian Elevance Health, Inc. (ELV) insider trading activity

Peter D Haytaian is EVP & Pres Carelon & CarelonRx of Elevance Health, Inc.. Currently has a direct ownership of 17,238 shares of ELV, which is worth approximately $6.33 Million. The most recent transaction as insider was on Nov 01, 2024, when has been sold 1,649 shares (Common Stock) at a price of $414.01 per share, resulting in proceeds of $682,702. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.2K

8.73% 3M change

2.82% 12M change

Total Value Held $6.33 Million

Peter D Haytaian Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 01 2024	SELL Payment of exercise price or tax liability	$682,702 $414.01 p/Share	1,649 Reduced 8.73%	17,238 Common Stock
Nov 01 2024	BUY Grant, award, or other acquisition	-	3,799 Added 15.3%	21,037 Common Stock
Mar 04 2024	SELL Open market or private sale	$10,551,297 $500.18 p/Share	21,095 Reduced 52.76%	18,887 Common Stock
Mar 04 2024	BUY Exercise of conversion of derivative security	$2,504,550 $166.97 p/Share	15,000 Added 27.28%	39,982 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$2,153,160 $499.11 p/Share	4,314 Reduced 24.32%	13,425 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	11,557 Added 31.63%	24,982 Common Stock
Nov 01 2023	SELL Payment of exercise price or tax liability	$68,785 $446.66 p/Share	154 Reduced 0.86%	17,739 Common Stock
Mar 02 2023	SELL Payment of exercise price or tax liability	$2,563,757 $468.78 p/Share	5,469 Reduced 23.41%	17,893 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$284,701 $469.03 p/Share	607 Reduced 5.07%	11,354 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	12,008 Added 33.95%	23,362 Common Stock
Nov 01 2022	SELL Payment of exercise price or tax liability	$108,906 $544.53 p/Share	200 Reduced 1.64%	11,961 Common Stock
Mar 10 2022	SELL Open market or private sale	$8,163,916 $461.16 p/Share	17,703 Reduced 59.28%	12,161 Common Stock
Mar 10 2022	BUY Exercise of conversion of derivative security	$243,566 $131.8 p/Share	1,848 Added 5.83%	29,864 Common Stock
Mar 02 2022	SELL Payment of exercise price or tax liability	$228,501 $463.49 p/Share	493 Reduced 1.73%	28,016 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$2,107,150 $451.5 p/Share	4,667 Reduced 20.55%	18,044 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	10,465 Added 26.85%	28,509 Common Stock
Nov 01 2021	BUY Grant, award, or other acquisition	-	1,167 Added 4.89%	22,711 Common Stock
Mar 22 2021	SELL Open market or private sale	$20,786,325 $349.35 p/Share	59,500 Reduced 72.52%	22,544 Common Stock
Mar 22 2021	BUY Exercise of conversion of derivative security	$5,308,641 $139.36 p/Share	38,093 Added 31.71%	82,044 Common Stock
Mar 02 2021	SELL Payment of exercise price or tax liability	$153,337 $311.66 p/Share	492 Reduced 1.11%	43,951 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$4,432,672 $311.48 p/Share	14,231 Reduced 43.6%	18,411 Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	26,032 Added 36.94%	44,443 Common Stock
Dec 15 2020	SELL Open market or private sale	$1,824,154 $312.73 p/Share	5,833 Reduced 15.16%	32,642 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	$857,043 $146.93 p/Share	5,833 Added 13.16%	38,475 Common Stock
Nov 16 2020	SELL Open market or private sale	$1,947,973 $333.9 p/Share	5,834 Reduced 15.16%	32,642 Common Stock

PDH

Peter D Haytaian

EVP & Pres Carelon & CarelonRx

Indianapolis, IN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELV shares.

Notify only if

Value

Insider Trading

Get notified when an Elevance Health, Inc. insider buys or sells ELV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Elevance Health, Inc.

Track Activities on ELV

Account